170 related articles for article (PubMed ID: 8615129)
1. Is dopaminergic cell death accompanied by concomitant nerve plasticity?
Anglade P; Blanchard V; Raisman-Vozari R; Faucheux BA; Herrero MT; Obeso JA; Mouatt-Prigent A; Kastner A; Strada O; Javoy-Agid F; Agid Y; Hirsch EC
Adv Neurol; 1996; 69():195-208. PubMed ID: 8615129
[No Abstract] [Full Text] [Related]
2. Are dopaminergic neurons selectively vulnerable to Parkinson's disease?
Agid Y; Ruberg M; Javoy-Agid F; Hirsch E; Raisman-Vozari R; Vyas S; Faucheux B; Michel P; Kastner A; Blanchard V
Adv Neurol; 1993; 60():148-64. PubMed ID: 8420132
[No Abstract] [Full Text] [Related]
3. Immune-mediated cell death in neurodegenerative disease.
Appel SH; Smith RG; Le WD
Adv Neurol; 1996; 69():153-9. PubMed ID: 8615124
[No Abstract] [Full Text] [Related]
4. [Physiopathologic mechanisms in acute progressive neuronal death: pharmaco-therapeutic consequences].
Lepagnol J
J Pharm Belg; 1997; 52(2):100-1. PubMed ID: 9296953
[No Abstract] [Full Text] [Related]
5. Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acids.
Gerlach M; Riederer P; Youdim MB
Adv Neurol; 1996; 69():177-94. PubMed ID: 8615127
[No Abstract] [Full Text] [Related]
6. A link between cholesterol, synapse plasticity, degeneration and neurological disorders: reinvention or integration?
Koudinov A
Bioessays; 2003 Jul; 25(7):736-7; author reply 737. PubMed ID: 12815729
[No Abstract] [Full Text] [Related]
7. Dopamine-induced, genotoxic activation of programmed cell death. A role in nigrostriatal neuronal degeneration in Parkinson's disease?
Ziv I; Barzilai A; Offen D; Stein R; Achiron A; Melamed E
Adv Neurol; 1996; 69():229-33. PubMed ID: 8615132
[No Abstract] [Full Text] [Related]
8. Origin of chorea-ballism and multisystem degeneration: pathophysiological implications.
Obeso JA; Luquin MR; Herrero MT; Guridi J
Mov Disord; 1993; 8(1):123-4. PubMed ID: 8419800
[No Abstract] [Full Text] [Related]
9. Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients.
Jan C; François C; Tandé D; Yelnik J; Tremblay L; Agid Y; Hirsch E
Eur J Neurosci; 2000 Dec; 12(12):4525-35. PubMed ID: 11122363
[TBL] [Abstract][Full Text] [Related]
10. Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits.
Calabresi P; Galletti F; Saggese E; Ghiglieri V; Picconi B
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S259-62. PubMed ID: 18267247
[TBL] [Abstract][Full Text] [Related]
11. Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
Hirsch EC
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S115-20; discussion S120-1. PubMed ID: 10762138
[TBL] [Abstract][Full Text] [Related]
12. Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease.
Hirsch EC; Hunot S; Damier P; Brugg B; Faucheux BA; Michel PP; Ruberg M; Muriel MP; Mouatt-Prigent A; Agid Y
Adv Neurol; 1999; 80():9-18. PubMed ID: 10410697
[No Abstract] [Full Text] [Related]
13. [Degeneration of catecholaminergic neurons].
Chatellard-Causse C; Feuerstein C
Pathol Biol (Paris); 1995 Sep; 43(7):577-80. PubMed ID: 8570260
[No Abstract] [Full Text] [Related]
14. Neurotoxicity and the mechanisms of cell death in Parkinson's disease.
Schapira AH
Adv Neurol; 1996; 69():161-5. PubMed ID: 8615125
[No Abstract] [Full Text] [Related]
15. Neurochemical correlates of parkinsonism. Role of dopaminergic lesions.
Hirsch EC; Herrero MT
Adv Neurol; 1997; 74():119-26. PubMed ID: 9348407
[No Abstract] [Full Text] [Related]
16. The histopathology of neuronal degeneration and plasticity in Alzheimer disease.
Kowall NW; McKee AC
Adv Neurol; 1993; 59():5-33. PubMed ID: 8420123
[No Abstract] [Full Text] [Related]
17. Neurodegenerative diseases and model systems.
Price DL; Borchelt DR; Wong PC; Pardo CA; Thinakaran G; Lee MK; Cleveland DW; Sisodia SS
Cold Spring Harb Symp Quant Biol; 1996; 61():725-38. PubMed ID: 9246498
[No Abstract] [Full Text] [Related]
18. Functional consequences of dopaminergic degeneration in Parkinson's disease.
Tedroff JM
Adv Neurol; 1999; 80():67-70. PubMed ID: 10410704
[No Abstract] [Full Text] [Related]
19. Aging, disease and death of nerve cells.
Agid Y; Hirsch E; Anglade P; Michel P; Brugg B; Ruberg M
Acta Neurol Belg; 1996 Sep; 96(3):219-23. PubMed ID: 8886107
[No Abstract] [Full Text] [Related]
20. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.
Xu J; Kao SY; Lee FJ; Song W; Jin LW; Yankner BA
Nat Med; 2002 Jun; 8(6):600-6. PubMed ID: 12042811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
